Who owns Bolt Biotherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BOLT from SEC Form 13F filings across 23 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 23 institutions disclosed 596,527 shares of Bolt Biotherapeutics, Inc. worth $2.3M — about 35.3% of shares outstanding; the largest disclosed holder is Sofinnova Investments, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
23
13F holders
$2.3M
value, 2026 filers
35.3%
of shares outstanding (596,527 sh)
2
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BOLT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Sofinnova Investments, Inc. | 137,721 | $530,226 | 0.0% | 8.1% | 0.0% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 98,625 | $379,706 | 0.0% | 5.8% | +27.7% |
| 3 | Vivo Capital, LLC | 72,414 | $278,794 | 0.0% | 4.3% | 0.0% |
| 4 | CITADEL ADVISORS LLC | 56,903 | $219,077 | 0.0% | 3.4% | +462.9% |
| 5 | T3 Companies, LLC | 38,000 | $146,300 | 0.2% | 2.2% | 0.0% |
| 6 | Board of Trustees of The Leland Stanford Junior University | 35,977 | $138,511 | 0.0% | 2.1% | 0.0% |
| 7 | Pfizer Inc | 31,305 | $133,832 | 0.1% | 1.9% | 0.0% |
| 8 | Lynx1 Capital Management LP | 30,800 | $118,580 | 0.0% | 1.8% | 0.0% |
| 9 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 27,500 | $105,875 | 0.1% | 1.6% | 0.0% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 19,119 | $73,622 | 0.0% | 1.1% | -33.6% |
| 11 | Shay Capital LLC | 15,438 | $59,436 | 0.0% | 0.9% | +3.6% |
| 12 | BlackRock, Inc. | 9,711 | $37,388 | 0.0% | 0.6% | 0.0% |
| 13 | VANGUARD CAPITAL MANAGEMENT LLC | 7,060 | $27,181 | 0.0% | 0.4% | 0.0% |
| 14 | Nan Fung Group Holdings Ltd | 5,000 | $19,250 | 0.0% | 0.3% | -82.9% |
| 15 | MORGAN STANLEY | 3,145 | $12,108 | 0.0% | 0.2% | -1.4% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 3,095 | $11,916 | 0.0% | 0.2% | 0.0% |
| 17 | NewEdge Advisors, LLCNEW | 2,530 | $9,740 | 0.0% | 0.1% | new |
| 18 | Tower Research Capital LLC (TRC) | 1,710 | $6,584 | 0.0% | 0.1% | +56.5% |
| 19 | UBS Group AG | 255 | $982 | 0.0% | 0% | -67.6% |
| 20 | SBI Securities Co., Ltd. | 130 | $501 | 0.0% | 0% | +1200.0% |
| 21 | JPMORGAN CHASE & CO | 42 | $165 | 0.0% | 0% | 0.0% |
| 22 | CITIGROUP INCNEW | 41 | $158 | 0.0% | 0% | new |
| 23 | BARCLAYS PLC | 6 | $23 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.